Patent · US Active

Nucleic acid delivery composition and carrier composition, pharmaceutical composition using the same, and method for nucleic acid delivery

US9314529B2 · kind B2 · utility

5Cited by
2References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 11, 2011
Grant dateApr 19, 2016
Priority date
Expiry dateAug 28, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC08G63/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An excellent nucleic acid delivery composition is provided which has reduced cytotoxicity and improved nucleic acid introduction efficiency and gene expression efficiency. The composition comprises: a block copolymer having an uncharged hydrophilic polymer segment and a cationic polymer segment; a cationic polymer; and a nucleic acid, wherein the mol percentage (B/H ratio) of the cationic groups of the block copolymer to the total cationic groups of the block copolymer and the cationic polymer is between 25% and 90%.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.